Acta Med. 2004, 47: 181-185
https://doi.org/10.14712/18059694.2018.88
The Multidrug Resistance and Apoptosis Evaluation in Acute Myeloid Leukemia Cells After the In Vitro Doxorubicin Treatment
Karolína Jankovičováa, Jan Krejsek
a, Otakar Kopecký
a, Jaroslava Voglová
b, Zuzana Škrabková
c, Jakub Novosad
a
aCharles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové, Department of Clinical Immunology and Allergology, Hradec Králové, Czech Republic
bCharles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové, Department of Clinical Hematology, Hradec Králové, Czech Republic
cCharles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové, Department of Medical Biophysics, Hradec Králové, Czech Republic
Received April 1, 2004
Accepted May 1, 2004
Crossref Cited-by Linking
- Song Xiaolu, Chen Yirui, Peng Ye, Wang Xiaogang, Zheng Sujie, Shi Fangfang, Lan Jianping, Zhang Peng-Yue: LncRNA-PAX8-AS1 Silencing Decreases Cell Viability, Enhances Apoptosis, and Suppresses Doxorubicin Resistance in Myeloid Leukemia via the miR-378g/ERBB2 Axis. Evidence-Based Complementary and Alternative Medicine 2022, 2022, 1. <https://doi.org/10.1155/2022/2295044>
